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The insulin therapy-mediated weight gain in patients with type 2 diabetes (T2D) may relate to 
altered physical activity patterns (1). In this study, we examined the hypothesis that initiation 
of insulin therapy would be associated with an increase sedentary behavior (i.e. sitting time) 
and lower low-, moderate- and vigorous-intensity physical activity, which subsequently relate 
to weight gain.  
 
We included 40 T2D patients who started insulin therapy, who were followed for a period of 
12-months. Patients were randomly selected from one university hospital, three non-
university teaching hospitals and four primary care practices. The decision to start insulin 
treatment was at the discretion of the responsible physician and was always based on failure 
of glycemic control while on oral glucose-lowering agents and diet. Measurements were 
performed before, 6-months and 12-months after initiation of insulin therapy. We examined 
body weight, waist/hip-circumference, fasting glucose, and HbA1c using standardized 
procedures. Free-living daytime physical activity was objectively measured (SenseWear Pro3 
Armband™, Body Media, Pittsburgh, PA, USA) (2). We examined: 1. Time (hours/day) spent 
in sitting (<1.5METs), low intensity physical activity (LPA, 2.1-3.0METs), and moderate-to-
vigorous physical activity (MVPA, >3.0METs), 2. Steps per day, and 3. Sit-to-stand 
maneuvers (transition from ≥5-minutes sitting to LPA). 
 
Across 12-months, body weight increased 2.9±4.5kg (P<0.05). This observation is largely in 
line with earlier findings (3). Furthermore, fasting glucose and HbA1c decreased across 12-
months (both P<0.05). Interestingly, we found an increase in sitting time and a decrease in 
LPA, but no change in MVPA (Figure 1A-C). Number of steps (7854±3936 to 6060±3022) 
and sit-to-stand maneuvers (20±5 to 18±6) significantly decreased (both P<0.05). These 
findings show an increase in sedentary behavior, rather than a decrease in physical activity 
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(including exercise time), that occurs simultaneously with an increase in body weight after 
initiation of insulin therapy. Since sedentary behavior replaced LPA, lower energy 
expenditure may relate to our observation (4). However we found no relation between 
changes in energy expenditure and weight gain (r=-0.195, P=0.227). Excessive caloric intake 
less likely explains our observation, since food diaries revealed no increase in caloric intake 
(1721±839 to 1460±367, P=0.074). 
 
T2D patients with BMI<30kg/m2 (64±10 years) showed less sitting time (P=0.012) and more 
LPVA (P=0.012) than those with BMI≥30kg/m2 (57±9 years). Surprisingly, upon insulin 
therapy, BMI and waist circumference increased in subjects with BMI<30kg/m2, but not in 
BMI≥30kg/m2. Similarly, patients with BMI<30kg/m2, but not with BMI≥30kg/m2, 
demonstrated an increase in sitting time and a decrease in energy expenditure and steps/day 
(data not shown). We found significant, positive relations between changes in weight and 
waist circumference versus sitting time (Figure 1D-E). This fits with previous work in non-
diabetic populations, where an increase in sedentary behavior was related to weight gain (5). 
T2D patients with BMI≥30kg/m2 did not demonstrate these relations (r=-0.186 and -0.041, 
P=0.474 and 0.879, respectively). A potential explanation for these unexpected between-
groups differences may relate to a ceiling effect in sedentary behavior in patients with BMI 
≥30kg/m2. Indeed, the average sitting time of 12.5-h makes it practically difficult to further 
increase sedentary behavior.  
 
We observed that the initiation of insulin therapy was associated with an increase in sedentary 
behavior and limited changes in MVPA. This suggests that increased sedentary behavior, 
especially in non-obese T2DM patients, may contribute to body weight gain after initiation of 
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insulin therapy.  These findings suggest that sedentary behavior assessment and intervention 
may be needed in T2D management. 
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FIGURE 1. A-C: Physical activity patterns in T2D patients at baseline (T0) and after 6 (T6) 
and 12 months (T12) of the start of insulin therapy, where patterns are presented as sitting 
(h/day, A), low-intensity physical activity (LPA in h/day, B) and moderate-to-vigorous 
physical activity (MVPA in h/day, C). The plot elements are presented as follows: the length 
of the box represents the interquartile range (the distance between the 25th and the 75th 
percentiles), the horizontal line in the box interior represents the median, and the vertical lines 
issuing from the box extend to the minimum and maximum values of the variables. *Post-hoc 
significantly different from T0 at P<0.05. D,E: Spearman correlations of change in sitting 
time between baseline and 12 months of insulin therapy and weight gain (D) and waist 
circumference (E) among T2D patients with baseline BMI <30kg/m2. Spearman rank 
correlation coefficients (r) are shown for each correlation. Solid lines indicate linear 
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